Results 151 to 160 of about 196,921 (249)

A computational model of coronary arteries with in-stent restenosis coupling hemodynamics and pharmacokinetics with growth mechanics. [PDF]

Sci Rep
Ranno A, Manjunatha K, Koritzius T, Steinbrecher I, Hosters N, Nachtsheim M, Nilcham P, Schaaps N, Turoni-Glitz A, Datz J, Popp A, Linka K, Vogt F, Behr M.   +13 more
europepmc   +1 more source

Cardiac Catheterization and Hemodynamics in a Multicenter Cohort of Children with Pulmonary Hypertension

, 2022
Erika B. Rosenzweig, Angela Bates, Mary P. Mullen, Steven H. Abman, Eric D. Austin, Allen D. Everett, Jeffrey R. Fineman, Jeffrey A. Feinstein, Rachel K. Hopper, John P. Kinsella, Usha Krishnan, Minmin Lü, Kenneth D. Mandl, J. Usha Raj, Nidhy P. Varghese, Delphine Yung, Stephanie S. Handler, Lynn A. Sleeper   +17 more
openalex   +2 more sources

Effectiveness and safety of combining thiazides with loop diuretics vs. loop diuretics monotherapy in patients with acute decompensated heart failure: A retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aims This study investigated factors associated with and outcomes of combined loop diuretics with hydrochlorothiazide (HCTZ) for acute decompensated heart failure (ADHF). Methods In this retrospective study, adults hospitalized for ADHF and who received intravenous loop diuretics between January 2016 and March 2023 were enrolled.
Chia‐Chen Hsu, Hsien‐Chih Chiu, Ju‐Chieh Wung, Yueh‐Ching Chou, Yuh‐Lih Chang, Chian‐Ying Chou, Chin‐Chou Huang   +6 more
wiley   +1 more source

Hemodynamic characteristics of dilated ascending aorta in patients with bicuspid aortic valve. [PDF]

J Cardiothorac Surg
Xia Y, Zhang X, Zhu S, Chen S, Dong W, Chen Z, Zhang N, Ou J, Zhu J, Chen D, Zheng T.   +10 more
europepmc   +1 more source

[Hemodynamic changes caused by cardiac arrhythmia].

, 2010
Vladimir Goldner
openalex   +1 more source

An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon‐like peptide‐1 and glucagon receptor in healthy subjects

British Journal of Clinical Pharmacology, EarlyView.
Aims Glucagon‐like peptide‐1 (GLP‐1) and glucagon dual receptor agonists are in clinical development for a range of metabolic conditions, including type 2 diabetes and obesity. The cardiovascular actions at these receptors are well studied, but less is known about their combination.
James Goodman, Victoria E. Parker, Carmel M. McEniery, Giovanni Di Stefano, Annette Hubsch, Evangelia Vamvaka, Jo Helmy, Fotini Kaloyirou, Navazh Jalaludeen, Peter Barker, Lutz Jermutus, Joseph Cheriyan, Philip Ambery, Ian B. Wilkinson   +13 more
wiley   +1 more source

ISUOG Consensus Statement on maternal hemodynamic assessment in hypertensive disorders of pregnancy and fetal growth restriction. [PDF]

Ultrasound Obstet Gynecol
Stampalija T, Lees C, Ghi T, Cornette J, Gyselaers W, Ferrazzi E, Mousa T, Spaanderman M, Thilaganathan B, Valensise H, Collaborators.   +10 more
europepmc   +1 more source

Fostamatinib and the risk of acute aortic dissection in immune thrombocytopenia

British Journal of Clinical Pharmacology, EarlyView.
Immune thrombocytopenia (ITP) is a rare autoimmune disorder characterized by platelet destruction. While most patients respond to first‐ or second‐line therapies, a small subset is multirefractory. Fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, is a therapeutic option in these cases.
Paul Dalmas, Alexis Theron, Rita Badaoui, Stéphane Zaffran, Rayid Mchinda, Joelle Micallef, Nicolas Schleinitz, Mikael Ebbo   +7 more
wiley   +1 more source

Correction: Is pulmonary vascular remodeling an intermediate link between hyperglycemia and adverse outcomes in patients with idiopathic pulmonary arterial hypertension? Insights from a multi-center cohort study. [PDF]

Cardiovasc Diabetol
Zhang S, Gao L, Li S, Luo M, Xi Q, Lin P, Zhao Z, Zhao Q, Yang T, Zeng Q, Huang Z, Li X, Duan A, Wang Y, Luo Q, Guo Y, Liu Z.   +16 more
europepmc   +1 more source

Pharmacokinetics of teicoplanin in paediatric patients—A systematic review of current literature

British Journal of Clinical Pharmacology, EarlyView.
Background and Objective Teicoplanin is commonly used in children to treat gram‐positive infections and is sometimes used off‐label prophylactically in surgical or paediatric oncology settings. The pharmacokinetics (PK) of teicoplanin in children exhibit considerable variability, such as in critically ill children or those with renal impairment.
Noa E. Wijnen, Daan J. Touw, Kim Klein, Gertjan J. L. Kaspers, Paola Mian   +4 more
wiley   +1 more source